Location History:
- Marseille, FR (2009)
- Marseilles, FR (2013)
Company Filing History:
1 out of 8 
1 out of 1,745 
1 out of 230 
Years Active: 2009-2013
Title: Innovations of Eric Mas in Glycopeptide Research
Introduction
Eric Mas is a notable inventor based in Marseilles, France. He has made significant contributions to the field of glycopeptide research, particularly in relation to type 1 diabetes. With a total of 2 patents, his work focuses on the development of glycopeptides derived from pancreatic structures.
Latest Patents
Eric Mas's latest patents include innovative glycopeptides that are designed to induce specific immunological reactions in patients suffering from type 1 diabetes. One of his patents describes a glycopeptide comprising 1 to 40 repeated C-terminal polypeptides, with 11 amino acids, of BSDL or FAPP. These polypeptides are glycosylated and bear glycosylated epitopes that trigger an immune response. The invention also details methods for purifying these glycopeptides from biological fluids or producing them recombinantly in genetically modified host cells. His work has significant implications for diagnostics and therapeutics in the medical field.
Career Highlights
Throughout his career, Eric Mas has worked with esteemed institutions such as Université de la Méditerranée and Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing the understanding of glycopeptides and their applications in medicine.
Collaborations
Eric has collaborated with notable colleagues, including Dominique Lombardo and Marie-Odile Sadoulet. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Eric Mas is a prominent figure in the field of glycopeptide research, with a focus on developing innovative solutions for type 1 diabetes. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.